The Yeastract team, is actively curating each regulation evidence code, association type and environmental condition.
Transcription Factor |
Target ORF/Genes |
References |
Evidence Code |
Evidence Experiment |
Association Type |
Strain |
Environmental Condition |
Mac1p
|
YPR124W
|
PubMed
Labbé S et al., J Biol Chem, 1997 Jun 20;272(25):15951-8Labbé S et al., J Biol Chem, 1997 Jun 20;272(25):15951-8 |
N/A |
|
N/A |
S288c |
N/A |
PubMed
Yamaguchi-Iwai Y et al., J Biol Chem, 1997 Jul 11;272(28):17711-8Yamaguchi-Iwai Y et al., J Biol Chem, 1997 Jul 11;272(28):17711-8 |
N/A |
|
N/A |
S288c |
N/A |
PubMed
Gross C et al., J Biol Chem, 2000 Oct 13;275(41):32310-6Gross C et al., J Biol Chem, 2000 Oct 13;275(41):32310-6 |
N/A |
|
N/A |
S288c |
N/A |
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
PubMed
Keller G et al., Eukaryot Cell, 2005 Nov;4(11):1863-71Keller G et al., Eukaryot Cell, 2005 Nov;4(11):1863-71 |
N/A |
|
N/A |
S288c |
N/A |
PubMed
Workman CT et al., Science, 2006 May 19;312(5776):1054-9Workman CT et al., Science, 2006 May 19;312(5776):1054-9 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
PubMed
Heo DH et al., Biochem J, 2010 Oct 15;431(2):257-65Heo DH et al., Biochem J, 2010 Oct 15;431(2):257-65 |
Indirect |
lacZ - wt vs TF mutant |
Negative |
S288c |
Copper treatment |
PubMed
Dong K et al., Mol Cell Biol, 2013 Oct;33(20):4041-50Dong K et al., Mol Cell Biol, 2013 Oct;33(20):4041-50 |
Direct |
DNA footprinting |
Positive |
S288c |
SD medium |
PubMed
Nasuno R et al., PLoS One, 2014 Nov 25;9(11):e113788Nasuno R et al., PLoS One, 2014 Nov 25;9(11):e113788 |
Direct |
ChIP |
N/A |
S288c |
100 microM SNAP (S-nitroso-N-acetylpenicillamine) |
PubMed
Voutsina A et al., Curr Genet., 2019 Jun;65(3):799-816Voutsina A et al., Curr Genet., 2019 Jun;65(3):799-816 |
Direct |
ChIP |
N/A |
FT5 |
FT5; SC medium with copper (CTR1 repression); 30.C; early-log phase |
Direct |
ChIP |
N/A |
FT5 |
FT5; SC medium (non-inducing); 30.C; early-log phase |
Direct |
ChIP |
N/A |
FT5 |
FT5; SC medium (shifted-inducing, copper); 30.C; early-log phase |
Indirect |
Northern blot - wt vs TF overexpression |
Negative |
FT5 |
FT5; SC medium 30.C; early-log phase |
PubMed
James Theoga Raj C et al., J Biol Chem, 2019 Apr 5;294(14):5562-5575James Theoga Raj C et al., J Biol Chem, 2019 Apr 5;294(14):5562-5575 |
Indirect |
RNA-seq - wt vs TF mutant |
Positive |
BY4742 |
SD medium |
Indirect |
RT-PCR - wt vs. TF mutant |
Positive |
BY4742 |
SD medium |
PubMed
, , ;():, , ;(): |
Indirect |
RT-PCR - wt vs TF overexpression |
Positive |
1308 |
NO-treated biofilm cells |
Indirect |
RT-PCR - wt vs. TF mutant |
Positive |
1308 |
NO-treated biofilm cells |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
|